| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/07/2010 | WO2010000013A1 A sulfated polysaccharide compound and the preparation and use thereof |
| 01/07/2010 | WO2009143024A3 Compounds and methods for kinase modulation, and indications therefor |
| 01/07/2010 | WO2009140448A8 Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 01/07/2010 | WO2009140204A3 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 01/07/2010 | WO2009121992A3 Use of maslinic acid for the treatment of diseases and the symptoms thereof by means of cox-2 inhibition |
| 01/07/2010 | US20100004753 Open-pore biocompatible surface layer for an implant, methods of production and use |
| 01/07/2010 | US20100004298 P-38 inhibitors |
| 01/07/2010 | US20100004261 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 01/07/2010 | US20100004217 Topical steroidal formulations |
| 01/07/2010 | US20100004183 Mineral collagen chelates and methods of making and using same |
| 01/07/2010 | US20100004172 Compositions for mucosal and oral administration comprising hcg fragments |
| 01/07/2010 | US20100003324 Vinpocetine and eburn amonine derivatives for promoting bone growth |
| 01/07/2010 | US20100003307 Composition and use of rar antagonists for promoting chondrogenesis |
| 01/07/2010 | US20100003304 Method of improving the osteoinductivity of calcium phosphate |
| 01/07/2010 | US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 01/07/2010 | US20100003249 Polypeptide constructs for topical administration |
| 01/07/2010 | US20100003248 Polypeptide constructs for rectal and/or vaginal administration |
| 01/07/2010 | US20100003233 Compositions and methods for treatment of microbial infections |
| 01/07/2010 | US20100003222 Methods for bone regeneration using endothelial progenitor cell preparations |
| 01/07/2010 | CA2729408A1 Triazole derivative or salt thereof |
| 01/07/2010 | CA2729343A1 Topical steroidal formulations |
| 01/07/2010 | CA2728492A1 Treatment |
| 01/07/2010 | CA2728301A1 Vinpocetine and eburnamonine derivatives for promoting bone growth |
| 01/06/2010 | EP2141150A1 Bicyclic compound and pharmaceutical use thereof |
| 01/06/2010 | EP2141148A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same |
| 01/06/2010 | EP2141146A1 Calcilytic compounds |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2139465A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 01/06/2010 | EP2139331A1 Compositions and methods relating to novel compounds and targets thereof |
| 01/06/2010 | EP1404360B1 Monodisperse mixtures of calcitonin drug-oligomer conjugates comprising polyethylene glycol, uses thereof, and methods of making same |
| 01/06/2010 | CN201375305Y Cervical vertebra caring pillow |
| 01/06/2010 | CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/06/2010 | CN100577633C CaSR antagonist |
| 01/06/2010 | CN100577194C Powder medicine for treating hyperosteogeny |
| 01/06/2010 | CN100577191C Ointment for treating bone diseases and its preparing method |
| 01/06/2010 | CN100577180C Application of gambogicacid in preparing medication for restraining angiogenesis |
| 01/06/2010 | CN100577176C Extractive of Chinese globeflower in short petal, effective content of anti inflammation and usage |
| 01/06/2010 | CN100577172C Pharmaceutical compositions for treatment of metabolic bone disease and preparation method thereof |
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/06/2010 | CN100577165C Medicinal composition for treating cold wet numbness and preparation method thereof |
| 01/06/2010 | CN100577161C New application of dendrobine |
| 01/05/2010 | US7642358 Antidiabetic agents; modulate insulin drug resistance |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642257 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors |
| 01/05/2010 | US7642252 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/05/2010 | US7642243 Administering C-type natriuretic peptide, guanyl cyclase (GC-B)-activating peptide |
| 01/05/2010 | US7641922 Preparation and application of transhintotalphenolic acid |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2465723C Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 01/05/2010 | CA2456183C Il-6/ds-sil-6r fusion protein |
| 01/05/2010 | CA2449098C Pharmaceutical compositions for the coordinated delivery of nsaids |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2405796C Methods and compositions for modulating alpha adrenergic receptor activity |
| 01/05/2010 | CA2392081C Pharmaceutically active isoindoline derivatives |
| 12/31/2009 | US20090326058 CaSR Antagonist |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090325982 Phosphodiesterase 4 inhibitors |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325960 Method for treating inflammatory diseases using rho kinase inhibitor compounds |
| 12/31/2009 | US20090325953 P38 kinase inhibiting agents |
| 12/31/2009 | US20090325936 Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| 12/31/2009 | US20090325933 Pyrimidinone Derivatives and Their Use as a Drug |
| 12/31/2009 | US20090325930 Selective estrogen receptor modulator |
| 12/31/2009 | US20090325884 Method for Detecting Autoantibodies Formed in Rheumatoid Arthritis |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090325865 Liquid Formulations of Pegylated Growth Hormone |
| 12/31/2009 | US20090325289 Process for the multiplication of stem cells |
| 12/31/2009 | US20090324745 Compositions and methods for nutrition supplementation |
| 12/31/2009 | US20090324675 Bioocompatible polymer compositions |
| 12/31/2009 | US20090324673 Method for producing bioactive composites |
| 12/31/2009 | US20090324605 Interferon alpha antibodies and their uses |
| 12/31/2009 | US20090324604 M-csf specific monoclonal antibody and uses thereof |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324598 Method for the treatment of inflammatory disorders |
| 12/31/2009 | US20090324560 Method for preparation of cartilage cell |
| 12/31/2009 | US20090324545 Polymorphic forms of (s)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)ureido)benzyl carbamate |
| 12/31/2009 | US20090324512 Polypeptide constructs for nasal administration |
| 12/31/2009 | DE202009012891U1 Mittel und Einrichtung zur Wärmebehandlung mit Erd- und Bienenwachsgemisch Means and equipment for the heat treatment of earth- and beeswax mixture |
| 12/30/2009 | WO2009158584A1 Dual adhesive technology |
| 12/30/2009 | WO2009158480A2 Stimulation of cartilage formation using reduced pressure treatment |
| 12/30/2009 | WO2009158452A1 Piperidinyl derivative as a modulator of chemokine receptor activity |
| 12/30/2009 | WO2009158446A2 Crystalline forms of ((((4-((5-(cyclopropylcarbamoyl)-2-methylphenyl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbonyl)(propyl)carbamoyl)oxy)methyl (4-(phosphonooxy)phenyl)acetate, method of preparation and use thereof |
| 12/30/2009 | WO2009157869A1 Enamel matrix derivative fraction c |
| 12/30/2009 | WO2009157858A1 Use of cyclolignans for the treatment of a hyperactive immune system |
| 12/30/2009 | WO2009157418A1 Carboxylic acid compound |
| 12/30/2009 | WO2009155730A1 A pharmaceutical composition for treating disease caused by immune disturbance and the extract from tuckahoe |
| 12/30/2009 | WO2009155656A1 Repair and/or reconstitution of invertebral discs |
| 12/30/2009 | WO2009106748A3 Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 12/30/2009 | WO2009106708A3 Azetidine derivatives, their preparation and their application in therapy |
| 12/30/2009 | EP2137531A2 Biased ligands for receptors such as the pth receptor |
| 12/30/2009 | EP2137141A1 Biphenyl-4-yl-sulfonic acid arylamides and their use as therapeutic agents |
| 12/30/2009 | EP2136814A1 Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture |
| 12/30/2009 | EP1562949B1 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 12/30/2009 | EP1487444B1 Use of pyridyl amides as inhibitors of angiogenesis |
| 12/30/2009 | CN101612402A Interferon antagonist and use of Flt3L interferon |
| 12/30/2009 | CN100575482C Novel cytokine zcytor17 ligand |
| 12/30/2009 | CN100574797C Plaster for treating osteopathy |
| 12/30/2009 | CN100574788C Oral Chinese traditional medicine composition for treating atrophic arthritis |
| 12/30/2009 | CN100574781C Animal medicine for treating gout, its preparation method and use |